Host Nate Kaufman brings Rich Helppie back for a discussion about healthcare access. A 30-day wait for a first oncology visit after hearing the word leukemia is not an edge case—it’s the new normal in a system where demand outpaces supply and incentives reward the wrong behaviors. Nate opens with a personal story that reveals how access feels when the stakes are life and death, then pulls back the lens to explain why it happens: a 12-year training pipeline for specialists, uneven reimbu...
All content for Richard Helppie's Common Bridge is the property of Richard Helppie and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Host Nate Kaufman brings Rich Helppie back for a discussion about healthcare access. A 30-day wait for a first oncology visit after hearing the word leukemia is not an edge case—it’s the new normal in a system where demand outpaces supply and incentives reward the wrong behaviors. Nate opens with a personal story that reveals how access feels when the stakes are life and death, then pulls back the lens to explain why it happens: a 12-year training pipeline for specialists, uneven reimbu...
Episode 282- Show Me The Money- A Closer Look at NIL. With Greg Dooley
Richard Helppie's Common Bridge
43 minutes
2 months ago
Episode 282- Show Me The Money- A Closer Look at NIL. With Greg Dooley
The college sports landscape is undergoing a revolution that few fans truly understand. In this eye-opening conversation, University of Michigan lecturer Greg Dooley breaks down the complex world of Name, Image, and Likeness (NIL) compensation that's transforming collegiate athletics from its century-old amateur foundations into something resembling professional sports. Dooley expertly navigates the various ways today's college athletes receive compensation—from traditional scholarships to c...
Richard Helppie's Common Bridge
Host Nate Kaufman brings Rich Helppie back for a discussion about healthcare access. A 30-day wait for a first oncology visit after hearing the word leukemia is not an edge case—it’s the new normal in a system where demand outpaces supply and incentives reward the wrong behaviors. Nate opens with a personal story that reveals how access feels when the stakes are life and death, then pulls back the lens to explain why it happens: a 12-year training pipeline for specialists, uneven reimbu...
